r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

GS

Ghiath M. Sukhtian

Insider · Director and 10% owner · OTLK

Ghiath M. Sukhtian files insider transactions with the SEC as a director and 10% owner of Outlook Therapeutics (OTLK). We hold 2 disclosed purchases and sales filed since 1 November 2017, 1 of them in the last 90 days.

  • Files forOTLK
  • Disclosed buys and sells2 in all, 1 in the last 90 days
  • Last disclosure14 August 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 31 March 2019 — 12 August 2026Director and 10% owner · Outlook Therapeutics (OTLK)34 Form 4 lines · source: SEC Form 4
  • Filed 31 October 2017 — 20 June 2018Director and 10% owner · Oncobiologics (ONS)10 Form 4 lines · source: SEC Form 4

Everything they disclosed

44 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.